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Abstract 
Recovery of stress-induced structural alterations in Posttraumatic Stress Disorder (PTSD) 
remains largely unexplored. This study aimed to determine whether symptoms improvement is 
associated with GM density changes of brain structures involved in PTSD. Two groups of PTSD 
patients were involved in this study. The first group was treated with Eye Movement Desensitization 
and Reprocessing (EMDR) therapy and recovered from their symptoms (recovery group) (n = 11); 
Patients were scanned prior to therapy (T1), one week (T2) and five months after the end of therapy 
(T3). The second group included patients which followed a supportive therapy and remained 
symptomatic (wait-list group) (n = 7). They were scanned at three time-steps mimicking the same 
inter-scan intervals. T1-weighted images of anatomical structure were acquired using magnetic 
resonance imaging (MRI) prior to therapy (T1). Voxel-based morphometry (VBM) was used to 
characterize GM density evolution. GM density values showed a significant group-by-time interaction 
effect between T1 and T3 in prefrontal cortex areas. These interaction effects were driven by a GM 
density increase in the recovery group with respect to the wait-list group. Symptoms removal goes 
hand-in-hand with GM density enhancement of structures involved in emotional regulation. 
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1. Introduction 
Posttraumatic Stress Disorder (PTSD) is a debilitating disorder characterized by 
repetition or revival, anxious hypervigilance, avoidance, and emotional numbing (Ursano et 
al., 2004). The neural correlates underlying PTSD symptomatology have garnered increasing 
attention and findings posit marked anatomical key structures as the neural basis underlying 
this pathology. For instance structural neuroimaging findings in PTSD patients have 
consistently highlighted GM volume reductions in the medial prefrontal cortex (mPFC) 
(Rauch et al., 2003) and in the hippocampus (Bremner et al., 1997) as compared to healthy 
controls. Volumetric studies of the amygdala however remain inconclusive as some authors 
have reported smaller amygdala in PTSD patients than in healthy controls (Rogers et al., 
2009), whereas others described no change (Yamasue et al., 2003) and others yet report an 
increased volume (Kuo et al., 2012). One recent meta-analysis has shown that PTSD was 
characterized by decreased volume in the hippocampus and the anterior cingulate cortex 
(ACC) when compared to trauma-exposed controls and unexposed controls 
2015). PTSD patients were also found to have smaller amygdala than trauma-exposed 
controls, but no differences were found between patients and non-exposed controls 
.  
From a functional viewpoint, increased amygdala activity and diminished ventro-
medial PFC (vmPFC) activity seem to be the most robust finding in PTSD patients vs. healthy 
controls. One study accordingly depicted a model of PTSD in which cortical capacity to 
inhibit fear responses elicited by the amygdala would be altered (Etkin and Wager, 2007). 
Hippocampal findings show less consistency with both reports of exaggerated (Shin and 
Liberzon, 2010), and diminished activity (Bremner et al., 2003). As such, a new functional 
meta-analysis characterizes PTSD as involving a hyperactive amygdala and hypoactive 
medial prefrontal regions, additionally suggesting a hyperactive hippocampus (Patel et al., 
2012). 
In parallel with humans studies, findings from animal experiments suggest altogether 
that chronic stress induces dendritic atrophy in the mPFC (Cook and Wellman, 2004) and the 
hippocampus (McKittrick et al., 2000), whereas it induces a volumetric increase in the 
amygdala (Vyas et al., 2003). Interestingly, after stress termination, recovery of stress-
induced alterations in the neuronal architecture is observed in both the hippocampus and the 
mPFC, while persistent dendritic growth and spine formation is retained in the amygdala 
(Roozendaal et al., 2009). 
Although to date neural and functional alterations in PTSD have been massively 
investigated; recovery of these functional and anatomical alterations remains largely 
understudied. As such, one study (Nardo et al., 2010) has shown that GM density was 
negatively correlated with trauma load in bilateral posterior cingulate, left anterior insula and 
right anterior parahippocampal gyrus. Further, GM volume increase was evidenced in the 
hippocampus of PTSD patients after medication (Vermetten et al., 2003) and Eye Movement 
Desensitization and Reprocessing (EMDR) therapy (Letizia et al., 2007). Moreover, an 
increased dorsolateral PFC (dlPFC) thickness was found after trauma recovery in disaster 
survivors compared to healthy controls (Lyoo et al., 2011). Yet to date, only one study has 
explored structural changes in the amygdala after recovery, revealing that left amygdala mean 
volume increased significantly after EMDR therapy (Laugharne et al., 2016). Functional 
decrease in amygdala activity was also reported after treatment in PTSD (Peres et al., 2011). 
With the current scarcity of studies on GM density changes after stress recovery, and 
the discrepant results available in the literature related to such changes, no firm conclusions 
can be drawn as to the potential brain reorganization after recovery from trauma in PTSD 
patients. The aim of the present study was thus to determine whether GM density of brain 
structures involved in PTSD changes with symptoms improvement, as compared to GM 
density in PTSD with persisting symptoms. We addressed this issue using a Voxel-Based 
Morphometry (VBM) longitudinal study with two groups of PTSD patients. One group was 
treated with EMDR and subsequently recovered (recovery group) whereas the other, who 
followed only a supportive therapy, remained symptomatic (wait-list group). 
To the best of our knowledge this is the first study to address changes in brain 
structures in PTSD immediately after symptoms removal and several months after. Based on 
the available literature defining brain regions involved in PTSD (Bremner et al., 2007; 
Francati et al., 2007; Wignall et al., 2004), as well as data from animal studies on stress-
induced structural remodeling (Radley et al., 2008, 2005, 2004; Vyas et al., 2004), we 
hypothesized that GM density would increase in the PFC, the bilateral hippocampus and 
parahippocampal gyrus with symptoms amelioration. Moreover, in accordance with the 
functional decrease in amygdala activity after treatment (Peres et al., 2011), we expected GM 
density in the amygdala to decrease after recovery.  
 
2. Materials and methods 
2.1. Participants 
A prospective, multi-center, non-randomized controlled clinical study compared two 
groups of patients suffering from PTSD. One group of patients (the recovery group) received 
EMDR therapy at the psychiatric whereas the other group 
(the wait-list group) had only supportive therapy at the psychiatric 
 in Marseille, France.  randomization was rendered unfeasible 
across the trauma centers mainly due to geographical distances. Diagnosis of PTSD was 
established according to the DSM-IV (Ursano et al., 2004). The Posttraumatic Checklist Scale 
(PCL-S) was used to assess the severity of PTSD symptoms along three dimensions (re-
experiencing, avoidance and hyper-arousal symptoms) (Ventureyra et al., 2002).  
Each group was scanned at three time points at the same fMRI center, in Marseille. 
Before each scan, participants were assessed with the DSM-IV and filled the PCL-S.  
Participants of the recovery group were recruited among trauma-exposed victims by 2 
psychiatrists at the psychiatric pole in Marseille, France. This 
group comprised a total of 19 adult outpatients who met the DSM-IV criteria for PTSD after a 
single traumatic event with no previous history of neurologic or psychiatric disorders. Once 
the diagnosis was established, participants were scanned at baseline (T1). Participants in this 
group were treated with EMDR. EMDR is an eight-step standardized psychotherapy validated 
by the American Psychiatric Association (APA) reports published in 2004, as a first line 
treatment for PTSD. Based on an information processing model, EMDR founder Shapiro et 
al., (2002) stipulate it includes associations of cognitive, emotional, and physical assessments 
of actual distress to traumatic scenery, as well as imaginal exposure. As the patient is asked to 
visualize the most salient aspect of a traumatic memory, the therapist induces bilateral 
alternate stimulations (by means of ocular, sensory-motor, or auditory stimulation) (Shapiro, 
1989). EMDR is an effective and rapid therapy with stable outcome reported in a 35-month 
follow-up study (Högberg et al., 2008). Patients were treated by one of 4 therapists trained by 
the French institute of EMDR. All therapists used ocular bilateral stimulations. There was no 
fixed number of sessions. One-hour sessions were planned every 7 to 15 days according to the 
availabilities of patients and therapists. The treatment was considered successful and complete 
when patients had no more symptoms, reported no more feelings of distress when thinking 
about their trauma and no longer met PTSD criteria according to DSM-IV. They also had to 
score below cut-off for psychopathology on the PCL-S scale. PTSD patients required an 
average of 2.5 (SD = 1.3) treatment sessions, ranging from 1 to 5 sessions. Individual sessions 
lasted around 1h and so the total mean time of EMDR therapy was 2h30 per patient on 
average. Symptom-free patients were then scanned for the second time one week after the 
symptoms removal (T2) and then the third and last time five months after T2 (T3).   
S
data was excluded from the analysis because of excessive head motion during image 
acquisition. Hence, the final recovery group included 11 adult outpatients (with 4 females). In 
its final makeup the recovery group included 1 patient on hypnotic medication, 2 patients on 
antidepressant, and 1 patient with a combination of anxiolytic, antidepressant and hypnotic. 
Eight participants had comorbid major depressive disorder (MDD) or other anxiety disorders. 
Characteristics of participants are described in Table 1. 
PTSD participants of the wait-list group were recruited among trauma-exposed victims 
by 2 other psychiatrists at the psychiatric pole of the -Marguerite Hospital  in 
Marseille, France. Patients of this group followed a supportive therapy only, and retained their 
symptoms throughout the study. The supportive therapy is a non-specified form of therapy, 
with limited goals, centered on the adaptation of patients. This psychotherapy does not share 
any of the active components of EMDR but rather combines supportive talk and empathy with 
suggestive resources (Rockland, 1989). It was administered by psychologists and psychiatrists 
of the - Patients of wait-list group were scanned at three time 
points T1, T2 and T3, with inter-scan intervals similar to the recovery group. At the end of the 
study, participants in this group were given the option to enroll in EMDR therapy. The wait-
list group initially included 16 adult PTSD outpatients who retained their PTSD diagnosis by 
T3. Between T2 and T3, 5 of them gave up on the study and 4 others were excluded from the 
final analyses because of excessive head motion during image acquisition. Hence, the final 
wait-list group included 7 outpatients (with 4 females). One patient in this group was on a 
stable regimen of antidepressant, 1 took both antidepressant and anxiolytic, 1 had anxiolytic 
only and 2 patients had a combination of anxiolytic, antidepressant and hypnotic. Two 
participants had comorbid MDD and another anxiety disorder, and 4 participants had only one 
comorbid anxiety disorder.  
The study was reviewed and approved by the local ethics committee (CPP South 
Mediterranean 2). All procedures were in accordance with the ethical standards of the 
committee on human experimentation (institutional and national) and with the Helsinki 
Declaration of 1975, and the applicable revisions at the time of the investigation. Informed 
consent was obtained from all patients for being included in the study. The registry name of 
 Its 
-A00193-54. 
Statistical analyses of demographic data were performed using SPSS (v18.0, SPSS 
Inc., Chicago, IL) and are depicted in Table 1. Demographic differences between groups were 
assessed with independent t-test at T1. Changes of PCL-S scores were assessed with a two-
way repeated measure ANOVA with Group (recovery / wait-list) as a between factor and 
Time (T1, T2, T3) as a within-subject factor. Post-hoc analyses were performed in order to 
detect changes in PCL-S scores between scans. Bonferroni correction was applied to correct 
for multiple-testing.  
As detailed in Table 1, the two groups were matched for education, age, PCL-S scores 
at T1 and interscan intervals (T2-T1, T3-T1 and T3-T2). The duration of illness between the 
two groups was not significant (p = 0.051).  
 
2.2. MRI acquisition parameters  
For the T1 (baseline), T2 and T3 scans, the structural brain data was acquired on a 3-T 
MEDSPEC 30/80 AVANCE imager (Bruker, Ettlingen, Germany) at the fMRI center of the 
Timone hospital in Marseille, France. High-resolution T1-weighted images were acquired 
using the following parameters: sagittal orientation, MPRAGE sequence, echo time = 4.42 
ms, repetition time = 9.4 ms, inversion time = 800 ms, flip angle = 30°, matrix = 
256*256*180, Voxel size = 1*1*1 mm3. The scanning time for the MPRAGE sequence was 
15 minutes. The total scanning time for each participant was 45 minutes. 
 
2.3. Voxel-Based Morphometry (VBM) Analysis 
VBM analyses were performed with the VBM8 toolbox (http://dbm.neuro.uni-
jena.de/vbm/) for SPM8 BM is an unbiased, semi-
automated technique that allows the characterization of regional differences across the whole 
brain (Mechelli et al., 2005). It is a recent and promising neuroimaging technique that allows 
the investigation of focal differences in brain anatomy (Nardo et al., 2010). It was used to 
characterize the differences in regional brain tissue concentration.  
Standard routines and default parameters of the VBM8 toolbox were applied for the 
main phases of the preprocessing and statistical analyses.  
Individual preprocessing steps were replicated as follows. First, the baseline and 
follow-up images of each subject were realigned with SPM8. This step aims to improve the 
quality of the normalization and segmentation steps in the pretreated images. Images were 
centered by laying the origin of axes on the anterior commissure in order to minimize 
potential normalization problems and to reduce magnetic field inhomogeneities. The mean of 
these realigned images was then calculated and used as a reference image in a subsequent 
realignment. The realigned images were corrected for inhomogeneities of the signal, with 
regard to the reference mean image. In the follow-up scans, the mean T1 image was 
segmented. Normalization parameters, estimated from the segmentation of the mean image, 
were then used to segment the bias-corrected images. Dartel deformations were then applied 
to normalize the segmented images into the MNI template (Montreal Neurological Institute). 
Finally, the resulting normalized segmented images were again realigned with one another. 
Unmodulated VBM identified differences in the relative concentration or density of grey or 
white matter (i.e., the proportion of grey or white matter relative to other tissue types within a 
region) (Mechelli et al., 2005). Once preprocessing was complete, we checked the quality of 
the images and removed unusual ones. Images were smoothed with an 8 mm FWHM (Full-
Width Half-Maximum) isotropic Gaussian filter and included in the GM analysis with a 
flexible factorial design.
Smoothed GM images were thresholded at a value of 0.1 to exclude any remaining 
non-GM tissue and entered in a flexible factorial design with Group (recovery / wait-list) and 
Time (T1, T2, T3) as categorical factors. To restrain the analysis to GM density a mask of 
GM was defined using the Automated Anatomical Labeling atlas (Tzourio-Mazoyer et al., 
2002) implemented in the WFU PickAtlas toolbox (Maldjian et al., 2003). 
We investigated potential difference between the two groups in the evolution of GM 
density across the three time points. To do so, we built three contrasts corresponding to the 
group-by-time interaction effects: 1) recovery group (T2-T1) - wait-list group (T2-T1); 2) 
recovery group (T3-T2) - wait-list group (T3-T2) and 3) recovery group (T3-T1) - wait-list 
group (T3-T1). The resulting statistic maps were corrected for multiple comparisons with a p 
< 0.05 family-wise error cluster-extent threshold (Bennett et al., 2009), using a primary 
statistical threshold at the voxel-level set at p < 0.001. GM density was then extracted in each 
significant cluster for each subject and time step point using SPM functions (spm_vol, and 
spm_read_vols). We then plotted the GM density mean difference of each cluster against time 
point in each group.   
3. Results 
3.1.  
PCL-S scores at each time point are given in Table 1. As previously noted, PCL-S 
scores were matched at T1. In the wait-list group, PCL-S scores did not change between T1 
and T2 (p = 1.000) and between T1 and T3 (p = 1.000), while it significantly decreased in the 
recovery group between T1 and T2 (p < 0.001) and between T1 and T3 (p < 0.001).  In the 
recovery group, EMDR was effective for all patients. Additionally, we observed a higher 
PCL-S score in the wait-list group than in the recovery group at T2 (p < 0.001), and T3 (p < 
0.001), with a significant group-by-time interaction (F (2, 32) = 25.34; p < 0.001).  
 
3.2. Longitudinal VBM results  
The results of the VBM analyses are illustrated in Fig 1 and summarized in Table 2.  
 
We found no significant group-by-time interactions for the contrast (recovery group (T3-T2) - 
wait-list group (T3-T2)) and for the contrast (recovery group (T2-T1) - wait-list group (T2-
T1)). We found no significant group-by-time interaction in the amygdala, in the hippocampus, 
or the parahippocampal gyrus. The group-by-time interaction for the contrast (recovery group 
(T3-T1) - wait-list group (T3-T1)) was significant in four clusters in the frontal lobe (Fig 1 
left). A first cluster was located in the right inferior frontal gyrus, including the dorsolateral 
prefrontal cortex and the orbitofrontal cortex (BA 46, 9, 10) (Fig 1A). A second significant 
cluster was found in the medial PFC (Fig 1B) comprising the dorsal ACC (BA 24, BA 32) 
(Fig 1B). A third significant cluster was observed in the right middle frontal gyrus (BA 6) 
(Fig 1C). Finally the fourth was situated in the bilateral mPFC (BA 9) (Fig 1D). In all 4 
clusters, group-by-time interaction effects were driven by a GM density increase with time in 
the recovery group as compared to the wait-list group, as depicted by plots of GM density 
evolution in Fig 1 (right). 
 
Figure 1. The significant clusters resulting from the VBM analysis (Pcluster-level <0.05 after 
FWE correction).  
 
 
The significant clusters resulting from the VBM analysis (Pcluster-level <0.05 after FWE 
correction). Three orthogonal views are shown on the left; corresponding plots of GM density 
evolution for each cluster are shown on the right. Significant cluster for the interaction 
contrast: recovery group (T3-T1)  wait-list group (T3-T1). A: Inferior frontal gyrus 
(dlPFC+OFC); B: Anterior cingulate cortex (BA 24/32); C: Middle frontal gyrus; D: Medial 
PFC (BA 9)
4. Discussion 
 
The aim of this study was to assess whether GM density in brain structures altered in 
PTSD changes with symptoms improvement. This study seems to provide evidence of 
significant group-by-time interactions driven by GM density increases post-EMDR, mostly in 
PFC structures.  
To the best of our knowledge, this is the first VBM study suggesting that GM density 
increases in the PFC with PTSD symptoms improvement. The cellular and molecular 
mechanisms underlying GM density increase in humans have yet to be elucidated to establish 
whether these changes are the result of an enhancement of dendritic spine density, dendritic 
length and branching complexity, or the expression of spine- and synapse-related proteins as 
in animals (Gross, 2000). Whatever the underlying mechanism, this GM density enhancement 
parallels existing data in animals; thereby suggesting a potential reversibility of stress-induced 
effects in the PFC (Roozendaal et al., 2009).  
PTSD is mostly characterized by severe deficits in emotion regulation processes and is 
marked by emotional hyper-reactivity to trauma-related cues (Ursano et al., 2004). Under 
normal conditions, the top-down regulation of emotions, specifically the regulation of 
negative emotions and subsequent behaviors, is known to involve the mPFC and the IFG, 
including the dlPFC and the OFC (Davidson, 2000). These prefrontal regions have 
consistently shown altered activity and decreased volumes in PTSD. Herein we show 
significantly increased GM density in these same prefrontal regions after symptoms 
improvement by EMDR. As anatomical structure may bi-directionally drive and underlie 
function, one putative explanation of symptom removal by EMDR could encompass the 
restoration of prefrontal volume after therapy, potentially countering the initial decrease in 
these regions activity in PTSD. This would thereby improved ability to better 
deal with and control their negative emotions. 
The present results parallel a previous study in which GM lower density in limbic and 
paralimbic cortices was found to be associated with PTSD diagnosis, trauma load, and EMDR 
treatment outcome (Nardo et al., 2010). Moreover, our results also parallel previous 
functional findings reporting successful restoration of prefrontal activity post-EMDR in 
PTSD, with significantly increased perfusion in the left frontal gyrus (Lansing et al., 2005), 
increased cerebral blood flow in the bilateral dlPFC (Oh and Choi, 2007), and increased 
activity in the mPFC, including the ACC (Levin et al., 1999). However, likely due to 
methodological differences with our experiment, other studies with larger sample size have 
shown that in patients suffering from PTSD, normalization of a tracer distribution in the 
perilimbic cortex occurred after successful EMDR therapy as compared to trauma exposed 
controls (Pagani et al., 2007). Moreover, it has been shown that GM lower density in limbic 
and paralimbic cortices was associated to PTSD diagnosis, trauma load, and EMDR outcome 
(Nardo et al., 2010). 
Furthermore, the trademark is an exaggerated 
response to fear, along with an inability to inhibit it (Charney, 2004). The prevailing 
hypothesis puts the hyperactive amygdala at the core of the disorder alongside a down-
regulated mPFC, ultimately failing to inhibit the limbic triggers (Hariri et al., 2000). Despite 
no changes found in the amygdala after symptom removal, significant GM density 
enhancement of the mPFC (BA 9, 24, 32) in the recovery group could unveil more potentiated 
mPFC that would become more efficient in regulating amygdala activity, ultimately driving 
fear extinction circuitry. Further longitudinal functional neuroimaging studies should verify 
that this GM density increase in prefrontal structures correlates with a restoration of central 
mechanisms involved in fear processing.  
Also, this study is the first of its kind to investigate differential impact of short and 
long term therapeutic benefits of symptoms improvement on brain structures in PTSD. We 
only found a between group difference of GM density evolution between the first and the 
third scan, but not between the first and the second scan or between the second and the third 
scan. This suggests that neuroanatomical changes do not occur or at least cannot be measured 
immediately after symptom improvement and require several months for stabilization. 
Despite the immediacy of the symptoms improvement, morphological PFC changes do not 
occur as soon as symptoms disappearance but several months after. Animal studies have 
shown that morphological changes after antidepressant administration are observable 
immediately after taking the drug, but its effect on brain plasticity lasts only as long as 
medication is administered (Burgdorf et al., 2015). Although PTSD symptoms had 
disappeared by T2, and were non existent at T3, GM density increase was only found between 
T1 and T3. This might suggest that the effect on the brain structures of EMDR psychotherapy, 
would take more time to initiate and potentiate than pharmacotherapy, but anatomical changes 
induced thereafter would last longer.  
Contrary to our initial hypotheses, we found no significant group-by-time interaction 
effects in the amygdala, the hippocampus, or the parahippocampal gyrus. Interestingly, when 
the conservative cluster-level FWE correction was not applied, a significant group-by-time 
interaction emerged for the T3-T1 interval at the voxel level (p < 0.001 uncorrected) in two 
clusters including the bilateral parahippocampal gyrus, the hippocampus, and the amygdala. 
Accordingly, this lack of result in limbic structures could be accounted for by the reduced 
statistical power related to the small sample size in this study. Another possible explanation 
could relate to methodological considerations. We have indeed proceeded with a longitudinal 
pipeline using the standard routines and default parameters of the VBM8 toolbox. Images 
obtained at the end of the preprocessing were unmodulated. Unmodulated VBM identified 
differences in the relative concentration or density of GM (i.e., the proportion of GM relative 
to other tissue types within a region), whereas modulated images identified GM volumes. One 
previous study reported differences between analyses of GM concentration and GM volumes 
(Good et al., 2001), especially in hippocampal regions (Keller et al., 2004). Therefore, using 
the GM volume analyses instead of GM density may have yielded changes in others regions 
than previously reported in our study, such as, most likely the hippocampus and the 
amygdala.  
The non-randomized design limits to some extent the interpretation of the group by 
time GM density changes. Moreover, the small sample size prevents the elaboration of a 
correlation between PTSD symptoms decrease and GM density increase in the recovery 
group. In spite of such limitation, our results suggest an association between GM density and 
EMDR therapy outcome, a finding with valuable clinical implications in PTSD treatment 
planning. Additional studies with larger groups of patients would be needed to replicate and 
further test for correlations between GM density changes and EMDR therapy outcome. 
Moreover, some of the patients were on stable medical regimen of antidepressants and/or 
anxiolytics and had other comorbid anxiety and/or mood disorders, all of which could 
potentially affect brain structures. Even though the duration of illness between the two groups 
was not significantly different, the effect size associated with this difference was large: 
d effect size d = 0.84 95% CI: -0.39-105.96. This indicates that the duration of illness 
between the recovery and the wait-list groups could introduce a confounding variable. Further 
studies including matched duration of illness between the groups would be recommended. 
Finally, for some significant clusters, at baseline, GM density in the recovery group was 
lower than for the wait-list group. This might be due to the heterogeneity of these two groups 
related to the type of trauma and the duration of illness since trauma. Yet, the aim of the study 
was to compare GM density evolution between the two groups and not merely to compare 
GM density between the two groups at each time point. It is thus noteworthy that despite 
these limitations, the validity of our results is strongly supported by the correction for 
multiple comparisons with a p < 0.005 family-wise error cluster-extent threshold. 
This work contributes to a better understanding of biological brain mechanisms 
underlying PTSD symptoms recovery.  It also 
helps promoting the use of psychotherapies such as EMDR as early as possible after traumatic 
 and structural alterations in 
the brain.  
Financial disclosures/conflict of interest
The authors report no competing interests  
Funding 
 
This research was partially supported by a grant from the Direction Générale de 
Assistance of Hospitals in Marseille), and by a grant from the EMDR Europe Association 
awarded to Stéphanie Khalfa.  
 
Acknowledgments  
We gratefully acknowledge all the PTSD participants for their time and involvement. 
We thank Bruno Nazarian and Jean-Luc Anton for their precious technical support and 
assistance with data collection.  
 
Table 1. Mean and Standard deviation (SD) for the demographical and clinical 
characteristics of participants 
Characteristics Recovery group 
n = 11 
Wait-list group 
n = 7 
p 
    
Gender, Male/Female 7/4 4/3 0.766 
Age, years 34.9 (10.0) 34.5 (8.1) 0.926 
Education, years 6.8 (2.6) 7.6 (2.3) 0.541 
Duration of illness, months 57.6 (79.1) 4.8 (2.8) 0.051 
Trauma type     
Agressions, n 4 6  
 
PCL-S: Posttraumatic Checklist Scale; T1: Time 1; T2: Time 2; T3: Time 3 
 
 
Table 2. VBM statistics for the -T1)  wait-list 
group (T3-  after FWE cluster-correction for multiple comparisons.  
Coordinates are given in MNI space. p = corrected p-value; k = cluster size; BA = Brodmann 
area. dlPFC: dorsolateral prefrontal cortex; OFC: Orbitofrontal cortex. 
 
 
road accidents, n  3 1  
armed robberies, n  1 0  
work-related accident, n  1 0  
witness of a suicide, n   1 0  
Torture, n  1 0  
Interscan Interval, months    
T2-T1 1.9 (1.6) 2.5 (2.8) 0.559 
T3-T1 7.3 (3.2) 10.3 (4.8) 0.129 
T3-T2 5.4 (2.0) 7.8 (3.8) 0.099 
PCL-S scores    
PCL-S T1 54.82 (8.90) 63.79 (14.55) 1.000 
PCL-S T2 23.91 (3.94) 61.64 (14.97) <0.001 
PCL-S T3 22.73 (4.27) 58.14 (12.56) <0.001 
     MNI 
coordinates 
  
Figure 1 Region and contrast side BA k x y z Z p 
 recovery group (T3-T1)  wait-list group (T3-T1)       
A Inferior frontal gyrus (dlPFC, OFC) R 46/9/10 1688 48 40 15  4.57 <0.001 
B Anterior Cingulate Cortex R/L 24/32 868 -4 6 43  4.47 <0.001 
C Middle frontal gyrus R 6 562 42 5 54  4.18 <0.001 
D Medial PFC R/L 9 812 -2 42 37  4.60 <0.001 
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Highlights:  
 This study explores the link between PTSD symptoms decrease and grey matter density 
increase in the prefrontal cortex.  
 GM density enhancement in prefrontal areas parallels existing data in animals; thereby 
suggesting a potential reversibility of stress-induced effects in the prefrontal cortex.  
 On the therapeutic edge, EMDR seems to be an efficient therapy to reduce PTSD symptoms 
and further restore brain structural organization. 
 
